Bruce W Bode Selected Research

Ketosis

6/2011

Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce W Bode Research Topics

Disease

41	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2002
39	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 05/2005
17	Type 2 Diabetes Mellitus (MODY) 12/2020 - 09/2003
12	Hyperglycemia 01/2022 - 10/2005
8	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 07/2013
7	Body Weight (Weight, Body) 01/2021 - 07/2011
5	Weight Gain 10/2018 - 01/2002
4	Weight Loss (Weight Reduction) 12/2020 - 07/2015
4	Critical Illness (Critically Ill) 01/2017 - 03/2004
2	Infections 09/2018 - 01/2016
2	Diabetes Mellitus 01/2007 - 11/2002
1	Diarrhea 09/2018
1	Nausea 02/2017
1	Obesity 02/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016
1	Cough 12/2015
1	Insulin Resistance 01/2013
1	Body Weight Changes 12/2011
1	Ketosis 06/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2009
1	Pain (Aches) 01/2007
1	Inflammation (Inflammations) 01/2007
1	Myocardial Infarction 03/2004

Drug/Important Bio-Agent (IBA)

49	Insulin (Novolin)FDA Link 01/2022 - 05/2002
35	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2005
11	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2004
11	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 08/2005
11	Insulin Aspart (NovoLog)FDA Link 01/2019 - 09/2003
6	Hemoglobins (Hemoglobin)IBA 01/2020 - 08/2010
5	Insulin Lispro (Humalog)FDA Link 01/2022 - 05/2005
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2019 - 09/2009
4	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021 - 07/2015
4	insulin degludecIBA 01/2019 - 08/2014
3	Sodium-Glucose Transport ProteinsIBA 06/2019 - 07/2015
3	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2018 - 07/2015
3	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2016 - 12/2011
3	Insulin Glargine (Lantus)FDA Link 08/2015 - 03/2005
2	Sitagliptin Phosphate (Januvia)FDA Link 12/2020 - 01/2013
2	Liraglutide FDA Link 02/2017 - 12/2011
2	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2016 - 01/2013
2	Metformin (Glucophage)FDA LinkGeneric 02/2016 - 07/2011
2	InsulinsIBA 01/2016 - 01/2007
2	SuspensionsIBA 05/2015 - 07/2013
2	C-PeptideIBA 10/2014 - 01/2013
2	Short-Acting InsulinIBA 01/2007 - 01/2002
1	semaglutideIBA 12/2020
1	Interleukin-7 (Interleukin 7)IBA 12/2019
1	monoclonal antibody RN168IBA 12/2019
1	Sodium-Glucose Transporter 1IBA 09/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2017
1	IDegLiraIBA 02/2017
1	DiamondIBA 01/2017
1	empagliflozinIBA 02/2016
1	Monoclonal AntibodiesIBA 10/2014
1	otelixizumabIBA 10/2014
1	Glucagon (Glukagon)FDA Link 01/2013
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2013
1	insulin glulisine FDA Link 06/2011
1	gamma-glutamylaspartic acidIBA 06/2011
1	IncretinsIBA 09/2009

Therapy/Procedure

29	Therapeutics 01/2021 - 01/2002
21	Glycemic Control 01/2022 - 01/2002
9	Injections 01/2022 - 01/2002
1	Intramuscular Injections 01/2016
1	Protective Devices (Safety Device) 01/2016
1	Drug Tapering 07/2015
1	Catheters 06/2011
1	Critical Care (Surgical Intensive Care) 03/2004